Penn Launches Trial to Evaluate Hydroxychloroquine to Treat, Prevent COVID-19
April 04, 2020
April 04, 2020
UNIVERSITY CITY, Pennsylvania, April 4 [TNSmedicalresearch] -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine (HCQ) can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether. The study, called Prevention and Treatment of COV . . .
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine (HCQ) can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether. The study, called Prevention and Treatment of COV . . .